France· FR:60687652
SORAFENIB SANDOZ 200 mg, comprimé pelliculé
A medicinal product containing tosilate de sorafénib, registered in France by SANDOZ, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TOSILATE DE SORAFÉNIB
- Manufacturer
- SANDOZ
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930209455112 plaquettes prédécoupées unitaires aluminium PVC polyéthylène PVDC de 1 comprimé(s)EUR 1.24
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tosilate de sorafénib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEXAVARBayer AG, Leverkusen
- United StatesNexavarBayer HealthCare Pharmaceuticals Inc.
- NetherlandsFENESA 200 mg filmomhulde tablettenZentiva k.s.
- FinlandNexavarOrifarm Oy
- SpainNEXAVAR 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
- PolandNexavarBayer AG
- SwedenNexavar 200 mg Filmdragerad tablettBayer AG
- BelgiumNexavar 200 mgBayer
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Sorafenib, Sorafenib Bluefish
- Belgium · Sorafenib Eg, Sorafénib Eg
- Bulgaria · Сорафениб Зентива, Сорафениб Тева
- Cyprus · Rexanib
- Czechia · Sorafenib Pharmagen, Sorafenib Sandoz
- Germany · Sorafeb, Sorafenib Abz
- Denmark · Sorafenib "sandoz", Sorafenib Stada
- Estonia · Sorafenib Sandoz, Sorafenib Teva
- Spain · Sorafenib Dr. Reddys, Sorafenib Eugia
- Finland · Sorafenib Sandoz, Sorafenib Stada
- United Kingdom (Northern Ireland) · Sorafenib Sandoz, Sorafenib Teva
- Greece · Revamox, Sorafenib Bioars
- Croatia · Slam 200 Mg Tablete, Sorafenib Alpha-Medical
- Hungary · Fenesa, Renixola
- Iceland · Nexavar, Sorafenib
- Italy · Sorafenib Eg, Sorafenib Medac
- Liechtenstein · Nexavar, Sorafenib Accord
- Lithuania · Sorafenib Sandoz, Sorafenib Teva
- Luxembourg · Sorafenib Eg, Sorafenib Eurogenerics
- Latvia · Sorafenib Lv System, Sorafenib Sandoz
- Malta · Revamox, Sorafenib Pharos
- Netherlands · Fenesa, Sorafeb
- Norway · Nexavar, Sorafenib Accord
- Poland · Sorafenib G.L., Sorafenib Sandoz
- Portugal · Sorafenib, Sorafenib Eugia
- Romania · Sorafenib Dr. Reddy's, Sorafenib Sandoz
- Sweden · Sorafenib Bluefish, Sorafenib Sandoz
- Slovenia · Sorafenib Sandoz, Sorafenib Teva
- Slovakia · Sorafenib, Sorafenib Pharmagen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a861769b-c81d-413b-814a-efbebfbcd052 GET /v1/drugs/a861769b-c81d-413b-814a-efbebfbcd052?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60687652",
"date_amm": "2020-06-15",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "TOSILATE DE SORAFÉNIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tosilate de sorafénib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.